Detalhe da pesquisa
1.
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Eur J Haematol
; 112(5): 788-793, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311570
2.
SARS-CoV-2-specific cellular response following third COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Haematologica
; 107(10): 2480-2484, 2022 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35734927
3.
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogenicity in humans.
NPJ Vaccines
; 9(1): 20, 2024 Jan 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38278816
4.
Systems biology analysis reveals distinct molecular signatures associated with immune responsiveness to the BNT162b COVID-19 vaccine.
EBioMedicine
; 99: 104947, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160529
5.
Flow cytometric protocol to characterize human memory B cells directed against SARS-CoV-2 spike protein antigens.
STAR Protoc
; 3(4): 101902, 2022 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36595922
6.
Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine.
Cell Rep Med
; 3(7): 100685, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35858586
7.
SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia.
Leukemia
; 36(2): 562-565, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34937858